GenAI initiatives are complex and—in some cases—costly. “As such, the main rationale for pursuing them needs to be business growth, not workforce reductions.” 

The authors of the survey report note that AI tools mentioned by respondents run the gamut from automated appointment reminders to dynamic “care gap” messaging. 

Some AI decision-support models have a proclivity for recommending aggressive care pathways. And doing so on the basis of patient demographics, not medical necessity.

In exclusive interviews, HealthExec spoke with the American Cancer Society about rising cancer rates, and a virtual provider service that's working to bolster struggling oncology staff.  

A data analysis from the Physicians Advocacy Institute and Avalere Health found corporate buyouts are leaving patients in low-population areas with fewer options, as doctors are opting to go elsewhere.

Is trial and error any way for a sprawling health system to roll out AI? Duke Health’s chief medical information officer believes so. 

Many if not most hospitals and other provider organizations take a decided interest in what their peer institutions are doing with AI. A major motivator for the keen curiosity is gauging how well one is keeping up with the Joneses. So to speak.

The FTC has back-burnered its price collusion case against CVS Caremark, Optum Rx and Express Scripts after significant staff departures at the agency left it uncertain how to proceed.